Anticancer drugs play a crucial role in the fight against cancer, targeting and eliminating malignant cells while sparing healthy tissue. Recent advancements in cancer research have led to the development of more precise and effective treatments, such as targeted therapies and immunotherapies. Targeted therapies focus on specific molecular alterations in cancer cells, offering a personalized approach to treatment. Immunotherapies harness the power of the body's immune system to recognize and attack cancer cells, providing long-lasting responses and reduced side effects compared to traditional chemotherapy. Additionally, combination therapies, which use multiple anticancer agents, have shown promise in overcoming drug resistance and improving patient outcomes. Continuous research and clinical trials are essential to discover novel drugs and optimize existing treatments, offering hope for more effective cancer management and improved survival rates.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States